Vigilance, rather than alarm, is needed to manage adverse events associated with bisphosphonate use for osteoporosis
Publisher: Adis International
ISSN: 1172-0360
Source: Drugs & Therapy Perspectives, Vol.28, Iss.2, 2012-02, pp. : 20-23
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Off-label Vistide use associated with serious adverse events
Reactions Weekly, Vol. 1, Iss. 1338, 2011-01 ,pp. :